Cosmetic Peptides

GHK-Cu (Copper Tripeptide-1)

For Research Use Only. Not for Human or Veterinary Use.

Overview

GHK-Cu is a copper(II)-binding tripeptide — glycyl-L-histidyl-L-lysine bound to a single copper ion — that occurs naturally in human plasma, saliva and other body fluids. It ranks among the most thoroughly documented cosmetic peptides, appearing across research on collagen synthesis, dermal-matrix remodeling, antioxidant defence, angiogenesis and wound repair. Its defining feature is a dual character: it both carries copper to copper-dependent enzymes and acts in its own right as a matrix-signalling peptide (a matrikine).

Chemical Profile

PropertyValue
CAS number89030-95-5 (GHK-Cu) · 49557-75-7 (GHK, free peptide)
INCI nameCopper Tripeptide-1
Amino-acid sequenceH-Gly-His-Lys-OH
One-letter codeGHK
Molecular formulaC₁₄H₂₄N₆O₄·Cu (copper complex)
Molecular weight (GHK)340.42 g/mol (free tripeptide)
Molecular weight (GHK-Cu)≈ 403.9 g/mol (copper complex)
Copper content≈ 13.6% w/w
Purity (HPLC)≥ 98%
AppearanceBlue to blue-violet lyophilized powder
GHK-Cu at a glance
Class
Copper-binding signal peptide (matrikine)
Natural source
Human plasma, saliva, urine
Research status
Extensive preclinical + human studies
Typical route
Topical (cosmetic research)
Plasma half-life (GHK)
~15 min (free peptide)
Key feature
Copper delivery + matrix signalling

Mechanism of Action

GHK-Cu is studied as both a copper ionophore and a signalling peptide, so its reported activity is usually described as several overlapping pathways rather than a single receptor event. The tripeptide holds copper(II) in a stable square-planar geometry and can hand that copper to copper-dependent enzymes, while the peptide backbone is investigated for direct effects on fibroblast gene expression.

PathwayResearch description
Collagen & ECMStudied for upregulation of type I and type III collagen, decorin and glycosaminoglycan synthesis in dermal-fibroblast models, often discussed alongside TGF-β signalling.
Copper transportInvestigated as a carrier that delivers Cu²⁺ to enzymes such as Cu/Zn-superoxide dismutase, lysyl oxidase and cytochrome c oxidase.
Antioxidant supportReferenced in research on antioxidant-enzyme activity and reduction of reactive-oxygen species in skin-cell models.
AngiogenesisAssociated in tissue-remodeling models with increased expression of angiogenic factors such as VEGF and bFGF.
Anti-inflammatory toneExplored in relation to inflammatory-signalling markers in repair models.
Tissue regenerationWidely cited for keratinocyte migration, granulation-tissue formation and re-epithelialization in wound-healing research.

Tissue-specific effects reported in the literature (research context, not product claims):

TissueStudied mechanismReported direction
DermisFibroblast activity + collagen I/III synthesisIncreased dermal density in models
EpidermisKeratinocyte migration and differentiationFaster experimental wound closure
VasculatureAngiogenic signalling (VEGF / bFGF)Enhanced tissue perfusion in models
Scar tissueModulation of the TGF-β1 / TGF-β3 balanceAltered scar remodeling in models

Pharmacology

ParameterValue
logP−2.5 (hydrophilic)
pKa≈ 6.8 (imidazole), 10.5 (ε-amino), 3.2 (α-carboxyl)
Copper-binding affinity (Kd)≈ 2.5 × 10⁻¹⁶ M (very high)
Topical bioavailability~1–3% unassisted; higher with liposomal / penetration-enhanced systems
Protein bindingHigh (albumin, transcuprein)
MetabolismProteolytic cleavage by plasma and tissue peptidases
EliminationRenal (peptide fragments); copper via biliary route

Research Evidence

GHK-Cu is one of the most frequently referenced copper peptides in cosmetic and dermatological literature, with both cell/tissue (preclinical) and human (clinical) studies. The directions and study types below summarise where the peptide appears in published work; they describe research contexts, not guaranteed outcomes.

Collagen & dermal matrix

Central to research on collagen synthesis, glycosaminoglycan production and dermal-matrix density in fibroblast and skin-explant models.

Wound healing & repair

Extensively studied for re-epithelialization, granulation-tissue formation and angiogenesis in experimental wound models.

Antioxidant & photodamage

Investigated in oxidative-stress and UV-exposure models in connection with antioxidant-enzyme activity.

Hair & scalp

Examined in dermal-papilla and hair-follicle models in the context of follicular signalling.

Preclinical research — representative models and what they investigate:

ModelResearch focusReference
Human dermal fibroblastsType I / III collagen synthesisMaquart FX, et al. (1993)
Fibroblast culturesSulfated glycosaminoglycan synthesisWegrowski Y, et al. (1992)
Human keratinocytesCell growth, morphogenesis and migrationSiméon A, et al. (2000)
Skin explants / wound modelsRe-epithelialization and angiogenesisPickart L, Margolina A (review)

Clinical research — the types of human study in which the ingredient is examined:

Study typeEndpoints studiedReference
Topical copper-tripeptide creamWound healing and skin recoveryAbdulghani AA, et al. (2008)
Facial photoaging formulationsFine lines, skin density and firmnessPickart L, Margolina A (review)

Representative reported directions from the literature (qualitative; GLP-1 entries reflect published clinical-trial results, others are reported study directions, not restated as precise product claims):

Reported direction / findingContextReference
Stimulates type I/III collagen and glycosaminoglycan synthesishuman dermal fibroblastsMaquart FX et al., 1993; Wegrowski Y et al., 1992
Promotes keratinocyte migration and wound repairkeratinocyte / skin modelsSiméon A et al., 2000
Antioxidant-enzyme support and copper deliveryoxidative-stress modelsPickart L, Margolina A (review)

For laboratory research and cosmetic formulation study only. Descriptions refer to published research contexts and are not product or health claims.

Formulation & Dosing Reference

ParameterValue
Typical topical concentration0.1–3.0% (w/w)
Common working range0.5–2.0%
Solubility in water≥ 50 mg/mL (clear blue solution)
Solubility in ethanolInsoluble
Recommended formulation pH5.0–7.0 (copper binding best preserved near 5.5)
Storage (powder)2–8°C, or −20°C long-term; sealed, dry, protected from light
  • Avoid strong chelators (EDTA, citrate) and reducing agents such as ascorbic acid, which can strip or reduce the bound copper.
  • Compatible with glycerin, propylene glycol, hyaluronic acid and standard oil-in-water emulsions.

Safety Profile

Safety data below refer to published toxicology and cosmetic-ingredient assessments of the ingredient itself and are provided for formulation research reference.

AssessmentReported result
Acute oral toxicity (rat)LD50 > 2000 mg/kg
Dermal irritation (rabbit)Non-irritant at 5%
Ocular irritation (rabbit)Mild, transient at concentrated solution
Skin sensitization (GPMT)Non-sensitizing
Mutagenicity (Ames)Negative
INCI statusApproved cosmetic ingredient (Copper Tripeptide-1)

Physicochemical Properties

PropertyValue
AppearanceBlue to blue-violet lyophilized powder
Solubility in water> 50 mg/mL (clear blue solution)
Solubility in DMSO10–20 mg/mL
Melting point> 200°C (decomposition)
pH (1% aqueous)5.5–6.5
Copper coordinationSquare-planar Cu(II) complex
UV-Vis λmax≈ 610 nm (d–d transition, the blue colour)
Light sensitivityModerate — store in the dark

Synthesis & Manufacturing

GHK-Cu is produced by solid-phase peptide synthesis (SPPS) of the GHK tripeptide, followed by controlled complexation with a copper(II) salt. The key manufacturing parameters below are typical for research-grade material.

StepDetail
StrategySolid-phase peptide synthesis, Fmoc/tBu chemistry
ResinWang resin (C-terminal acid)
CouplingHATU / HBTU with DIPEA
Deprotection20% piperidine in DMF
CleavageTFA / TIPS / H₂O (95 : 2.5 : 2.5)
PurificationPreparative reversed-phase HPLC (C18, TFA/ACN gradient)
Copper complexationCopper(II) acetate, aqueous, pH ≈ 5.5
  • Copper(II) acetate is preferred over sulfate or chloride for cleaner complexation and easier purification.
  • Complexation pH is critical: below ~4.0 the histidine imidazole cannot coordinate copper; above ~7.0 copper hydroxide can precipitate.
  • The blue-violet colour of the finished powder confirms correct square-planar Cu(II) coordination.

Analytical Methods

MethodPurposeTypical result
RP-HPLC (C18, UV 214 nm)Purity≥ 98%
ESI-MS (positive mode)Identity / mass confirmationm/z consistent with GHK and the Cu complex
ICP-MSCopper content≈ 13–14% w/w
UV-Vis (λmax 610 nm)Copper coordinationCharacteristic d–d transition band
CD spectroscopyCu(II) geometryConsistent with a square-planar complex
Amino-acid analysisCompositionGly : His : Lys = 1 : 1 : 1
Karl FischerWater content< 5%
TGAThermal decomposition onset> 200°C

Representative RP-HPLC purity method:

  • Column: C18, 5 µm, 250 × 4.6 mm
  • Mobile phase A: 0.1% TFA in water · Mobile phase B: 0.1% TFA in acetonitrile
  • Gradient: 20–40% B over ~20 min · Flow rate: 1.0 mL/min
  • Detection: UV 214 nm (peptide bond) together with 610 nm (Cu(II) d–d band)
  • Dual-wavelength detection confirms the peptide and the intact copper complex at the same time.

Stability Data

Representative stability behaviour under common storage and formulation conditions. The lyophilized powder is robust; solution stability depends on temperature and pH, and the copper complex is the part most sensitive to strong chelators and light.

ConditionDurationResult
Lyophilized powder, 2–8°C, dark≥ 24 monthsNo significant degradation
Lyophilized powder, 25°C, dark≥ 12 monthsMinimal degradation
Aqueous solution, pH 5.5, 4°C, dark≈ 7 daysMinor; copper retained
Aqueous solution, pH 5.5, 25°C≈ 48 hMinor; copper retained
Aqueous solution, pH 5.5, 40°CHoursCopper begins to dissociate
Formulated cream / emulsion, 25°C12 monthsPeptide and copper largely retained
Freeze–thaw (−20°C ⇄ 25°C)3 cyclesAcceptable
  • Copper binding is very strong, but the complex dissociates below pH ≈ 4.0 or with strong chelators such as EDTA and citrate.
  • The copper chromophore is moderately light-sensitive — store in opaque containers.
  • In formulation, avoid EDTA, citric acid and ascorbic acid (which can reduce Cu²⁺); the peptide is compatible with glycerin, propylene glycol, hyaluronic acid and standard oil-in-water emulsions.

Selected References

Representative peer-reviewed literature on GHK and GHK-Cu. Listed for research reference; individual findings are not restated here as product claims.

  • Pickart L. The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition.
  • Maquart FX, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide–copper complex GHK-Cu. FEBS Letters, 1993.
  • Wegrowski Y, et al. Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide–copper complex GHK-Cu. Biochemical Journal, 1992.
  • Siméon A, et al. Effects of glycyl-histidyl-lysine and its copper complex on human keratinocytes. Journal of Investigative Dermatology, 2000.
  • Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide. International Journal of Molecular Sciences.

Quality & Supply

  • HPLC ≥ 98% purity with a Certificate of Analysis per batch
  • Identity confirmed by LC-MS; copper content verifiable by ICP-MS
  • Research samples through to bulk, with worldwide delivery
  • Custom packaging and related copper peptides on request

Need GHK-Cu — sample or bulk?

HPLC-verified, COA per batch. Tell us the quantity you need.

Request a Quote